Euroklinika sp. z o.o.

Hospital activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-02-04
Share capital
270,000.00 PLN
Activity description

Euroklinika is a medical clinic in Bielsko Biała that offers primary healthcare and access to over 30 specialized medical offices. The clinic provides a range of services including general surgery, vascular surgery, proctology, gynecology, urology, dermatology, and pulmonology, employing highly qualified doctors with advanced specializations. Additionally, it offers pediatric care and various diagnostic and treatment options for different medical conditions.

Registered address
Żółkiewskiego 40, 43-300 Bielsko-Biała, Poland
Opening hours
Mon–Fri, 8:00–20:00
Email
Phone
Electronic delivery address
AE:PL-66959-27883-EAFUT-32

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$18,143

Filing timeliness

Financial statements were filed on time, on average 27 days early.

  • 202507/07/2026
  • 202411/07/2025
  • 202306/06/2024
  • 202204/07/2023
  • 202124/06/2022
  • 202027/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Hospital activities287 / 615
Top 47%
Division · Human health activities536 / 6,271
Top 8.6%
City · Bielsko-Biała267 / 2,711
Top 9.8%
Voivodeship · Śląskie3,590 / 33,148
Top 11%
Country · Poland32,781 / 297,069
Top 11%

Results vs industry

Revenue
This companyUSD 5.09mMedianUSD 3.28mAverageUSD 13.52m
Net profit
This companyUSD 56.15kMedianUSD 60.77kAverageUSD 252.46k
Operating costs
This companyUSD 5.02mMedianUSD 2.99mAverageUSD 12.86m
Assets
This companyUSD 1.30mMedianUSD 2.21mAverageUSD 10.96m

Websites

  • euroklinika.plEuroklinika | medical center in Bielsko-Biała
    Google AnalyticsApache

Public procurement

The company is the contractor in 3 public sector contracts, worth USD 7.00k in total. They were signed with 3 public buyers.

SubjectAmount
Provision of healthcare services
$2,801
Provision of healthcare services
$1,556
Provision of healthcare services – delivery of a preventive screening package for employees
$2,645

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2008. In 2026 it is performing 3 contracts with a total value of USD 1.69m. All its contracts were worth USD 17.07m in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Inpatient treatmentśląskie1USD 1.27m
Outpatient specialist careśląskie1USD 388.28k
Primary health careśląskie1USD 28.45k

NFZ waiting lists

This company's facilities run 12 NFZ waiting lists. Waiting time forecast by NFZ, as of 15.11.2026.

ServiceWaiting time
Day treatment wardno wait
Day treatment ward1 mo 2 wk
Day treatment ward4 mo
General surgery clinic5 mo 1 wk
General surgery clinic6 mo

Authorized Representatives

Tomasz Andrzej Kozik age 62 – Vice Prezes
Katarzyna Danuta Depa-Dębowska age 63 – Vice Prezes

Manner of representation

In the case of a multi-member management board, the President of the Management Board independently, or two members of the management board jointly, or one member of the management board jointly with a commercial proxy, is authorized to make declarations of will and sign on behalf of the company.

Ownership

OwnerSharesShare valueStake
13$3,511.624.8148%
13$3,511.624.8148%
109$29,443.5440.3704%
65$17,558.0824.0741%
50$13,506.2118.5185%
Others
20$5,402.497.4074%

Katarzyna Danuta Depa Dębowska, Anna Katarzyna Dębowska and Jan Janusz Dębowski hold a combined 50% – the ownership structure indicates family control.

Beneficial owners

Person

Subsidiaries

NameStake
–

Bank accounts

Registered as a VAT taxpayer on 2000-05-24.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $129,571.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$10,509
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$7,093
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$7,464

Change history

DateEvent
2025-10-28Switch to PKD 2025
2022-01-10PKD change
2013-05-20Address change
2009-07-13Switch to PKD 2007
2007-10-22Share capital increase

FAQ

Last updated: 2026-07-09